These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 22594581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS, Carpenter MA, Ivanova A, Gravens-Mueller L, John AA, Weir MR, Pesavento T, Bostom AG, Pfeffer MA, Hunsicker LG.
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial.
    Malhotra R, Katz R, Weiner DE, Levey AS, Cheung AK, Bostom AG, Ix JH.
    Am J Hypertens; 2019 Aug 14; 32(9):816-823. PubMed ID: 31179500
    [Abstract] [Full Text] [Related]

  • 9. Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Horace RW, Roberts M, Shireman TI, Merhi B, Jacques P, Bostom AG, Liu S, Eaton CB.
    Nephrol Dial Transplant; 2022 Jan 25; 37(2):382-389. PubMed ID: 33760035
    [Abstract] [Full Text] [Related]

  • 10. Baseline characteristics of participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
    Bostom AG, Carpenter MA, Hunsicker L, Jacques PF, Kusek JW, Levey AS, McKenney JL, Mercier RY, Pfeffer MA, Selhub J, FAVORIT Study Investigators.
    Am J Kidney Dis; 2009 Jan 25; 53(1):121-8. PubMed ID: 19022547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial).
    Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT, Shlipak MG, Ix JH.
    Am J Kidney Dis; 2021 Jul 25; 78(1):48-56. PubMed ID: 33333147
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.
    Kang AW, Bostom AG, Kim H, Eaton CB, Gohh R, Kusek JW, Pfeffer MA, Risica PM, Garber CE.
    Nephrol Dial Transplant; 2020 Aug 01; 35(8):1436-1443. PubMed ID: 32437569
    [Abstract] [Full Text] [Related]

  • 19. 24-hour urine phosphorus excretion and mortality and cardiovascular events.
    Palomino HL, Rifkin DE, Anderson C, Criqui MH, Whooley MA, Ix JH.
    Clin J Am Soc Nephrol; 2013 Jul 01; 8(7):1202-10. PubMed ID: 23539231
    [Abstract] [Full Text] [Related]

  • 20. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes.
    Foster MC, Hwang SJ, Larson MG, Parikh NI, Meigs JB, Vasan RS, Wang TJ, Levy D, Fox CS.
    Arch Intern Med; 2007 Jul 09; 167(13):1386-92. PubMed ID: 17620532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.